Clinic
Columbia Medical Center of Las Colinas INC
Columbia Medical Center of Las Colinas INC was paid $3.28M by Medicaid between Dec 2019 and Dec 2024, across 51 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.
33Billing provider infoCOLUMBIA MEDICAL CENTER OF LAS COLINAS INC
IRVING, TX 75039
IRVING, TX 75039
33aNPI1902857766assigned 05/15/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$3.28M
24GClaims55,747
24DCodes billed51
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#100 of 320
Median peer was paid$205K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 54 | $0.00 | |
| 2020 | 2,821 | $120K | |
| 2021 | 10,600 | $528K | |
| 2022 | 19,904 | $1.19M | |
| 2023 | 15,808 | $1.10M | |
| 2024incomplete | 6,560 | $343K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 45% | 9,013 | 8,664 | $1.46M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 5,107 | 4,637 | $1.25M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.4% | 1,530 | 1,359 | $111K |
| 80053 | Comprehensive metabolic panel | 1.8% | 2,208 | 1,932 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 2,304 | 2,245 | $54K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 7,208 | 6,313 | $50K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 1,380 | 1,128 | $40K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 280 | 275 | $39K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,601 | 3,357 | $31K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,558 | 1,348 | $22K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,849 | 1,665 | $19K |
| 81001 | <1% | 1,983 | 1,796 | $18K |
39 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 257 | $15K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 45 | $15K |
| 85027 | <1% | 5,224 | $14K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 656 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 99 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 991 | $7K |
| 86171 | <1% | 143 | $7K | |
| 81025 | <1% | 1,364 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,782 | $4K |
| 81003 | <1% | 417 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 304 | $4K |
| 84484 | <1% | 1,177 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 631 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 47 | $3K |
| 83880 | <1% | 619 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 369 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 26 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 225 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 26 | $2K |
| 76801 | <1% | 31 | $2K | |
| 83690 | <1% | 1,028 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 38 | $963.63 |
| 86850 | <1% | 73 | $945.94 | |
| 83655 | <1% | 79 | $743.81 | |
| 85014 | <1% | 66 | $665.89 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 42 | $577.39 |
| 86900 | <1% | 442 | $552.02 | |
| 85018 | <1% | 66 | $538.25 | |
| 86901 | <1% | 444 | $502.80 | |
| 84702 | <1% | 74 | $480.32 | |
| 85610 | <1% | 293 | $231.67 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 147 | $91.03 |
| 85730 | <1% | 127 | $79.77 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 154 | $74.81 |
| 80047 | <1% | 33 | $25.82 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 88 | $21.59 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | $5.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $1.87 |
| A9270 | Non-covered item or service | 0% | 66 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTROCHESSET, STEPHEN (CFO)